Several embodiments of the present disclosure relate to therapeutic compositions configured to target the liver of a subject and that are useful in the treatment or prevention of one or more of transplant rejection autoimmune disease food allergy and immune response against a therapeutic agent. In several embodiments the compositions are configured to target the liver and deliver antigens to which tolerance is desired. In several embodiments the compositions are configured for clearance of a circulating protein or peptide or antibody associated with one or more of the above mentioned maladies. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.
